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Abstract
Objectives: To evaluate the use and reporting of adjusted analysis in randomised controlled trials (RCTs) and compare 
the quality of reporting before and after the revision of the CONSORT Statement in 2001.
Design: Comparison of two cross sectional samples of published articles.
Data Sources: Journal articles indexed on PubMed in December 2000 and December 2006.
Study Selection: Parallel group RCTs with a full publication carried out in humans and published in English
Main outcome measures: Proportion of articles reported adjusted analysis; use of adjusted analysis; the reason for 
adjustment; the method of adjustment and the reporting of adjusted analysis results in the main text and abstract.
Results: In both cohorts, 25% of studies reported adjusted analysis (84/355 in 2000 vs 113/422 in 2006). Compared 
with articles reporting only unadjusted analyses, articles that reported adjusted analyses were more likely to specify 
primary outcomes, involve multiple centers, perform stratified randomization, be published in general medical 
journals, and recruit larger sample sizes. In both years a minority of articles explained why and how covariates were 
selected for adjustment (20% to 30%). Almost all articles specified the statistical methods used for adjustment (99% in 
2000 vs 100% in 2006) but only 5% and 10%, respectively, reported both adjusted and unadjusted results as 
recommended in the CONSORT guidelines.
Conclusion: There was no evidence of change in the reporting of adjusted analysis results five years after the revision 
of the CONSORT Statement and only a few articles adhered fully to the CONSORT recommendations.
Introduction
Adjusted Analysis in Randomised Controlled Trials
The randomised controlled trial (RCT) is widely accepted
as the 'gold standard' design for comparing the effects of
health care interventions. Randomisation aims to prevent
bias in the allocation of patients to treatment and pro-
duce unbiased estimates of treatment effects, but it does
not guarantee comparability, particularly in small trials.
Adjustment for baseline covariates in the analysis of an
RCT is less common than in epidemiological studies.
There are four main reasons to consider covariate adjust-
ment methods in RCTs [1-5]: first, to correct for imbal-
ances in baseline prognostic covariates despite
randomisation; second, to increase power by modelling
the variability in outcome explained by relationships with
highly prognostic covariates; third, to obtain treatment
effect estimates that would be more closely relevant to
individual patients than to an average population; and
finally to account for features of study design in the analy-
sis, such as covariates that are used in stratified randomi-
sation. Guidelines suggest that adjusted analysis,
including methods of adjustment and choice of covari-
ates, should be pre-specified in the trial protocol [6-8]. In
practice, however, adjustment may be done only when
baseline imbalance is seen in some covariates [9,10].
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CONSORT Guidance on Adjusted Analysis
The CONSORT Statement, first published in 1996 and
revised in 2001, provides recommendations for reporting
parallel groups RCTs. It has received considerable sup-
port and has been endorsed by many journals and edito-
rial groups worldwide. While briefly mentioned in the
1996 version, the 2001 revision elaborated the recom-
mendations for reporting of adjusted analysis. This
includes specification of the rationale for any adjusted
analysis, statistical methods used, and clarification of the
choice of variables used for adjustment. When reporting
results, CONSORT recommends reporting both unad-
justed and adjusted analyses, and stating whether the
adjusted analysis was planned. However, information on
the extent and quality of such practices in published
papers is lacking.
In this study, we carried out a systematic review of two
cohorts of publications indexed in PubMed to determine
the use and reporting of adjusted analysis in RCTs. We
also compared the quality of reporting before and after
the revision of the CONSORT Statement in 2001.
Methods
Study selection
This review included two cohorts: (1) articles published
in December 2000 and indexed in PubMed, as previously
identified by Chan et al [11,12]; (2) a newly identified
cohort of articles indexed in December 2006 in PubMed
(as of 22 March 2007). Both cohorts were identified by
searching PubMed using the extended version of Phase 1
of the Cochrane Highly Sensitive Search Strategy for tri-
als [13]. The abstracts of the search results for December
2006 were screened by one of the authors (LY). Based on
the abstract, all articles that were obviously not trials
were excluded. The full text of all remaining articles was
fully reviewed (LY) to assess their eligibility.
We included in this review RCTs of parallel group
design with a full publication carried out in humans and
published in English. Articles published as a letter or brief
communication, and articles reporting phase I or pilot
studies were excluded. We also excluded studies that did
not provide sufficient information on statistical analysis
or did not perform any formal comparison between treat-
ment groups.
Defining adjusted analysis
We identified all trial outcomes that were explicitly
reported to have undergone adjusted analysis for com-
parisons between randomised groups in either the Meth-
ods or Results section of the article. We sought mention
of the statistical analysis of the treatment effect account-
ing for covariates or an explicit statement that some
results were adjusted. Analyses that used multiple regres-
sion methods to identify prognostic variables or risk fac-
tors were not defined as adjusted analysis.
Data extraction
Information on trial characteristics and all outcomes
were extracted from the 2006 articles using the same def-
initions as those in the 2000 cohort [13]. Briefly, the pri-
mary outcome reported in the articles was defined if it
was explicitly specified in the article, an outcome used in
the power calculation, or a main outcome described
explicitly in the primary study objectives. Multi-center
involvement was defined as data being collected from
more than one study site; sample size was defined as the
total number of participants randomised in the study.
To maintain independence of observations, we selected
one outcome for each trial if more than one outcome
underwent adjusted analysis. We selected the outcome
according to the following hierarchy: (1) it was a pre-
specified primary outcome; (2) the sample size of the trial
was based on this outcome; or (3) it had most informa-
tion on adjusted analysis reported in the article. If more
than one outcome was equally reported within an article,
then the outcome was chosen at random.
For articles in both cohorts reporting adjusted analysis
we assessed the types of analysis reported explicitly in the
Methods and Results sections. Articles were classified as
reporting unadjusted analysis, adjusted analysis, both, or
unspecified/unclear. We also recorded the reason for
adjustment, the method of adjustment, and details of the
covariates used in the analysis. We assessed whether the
unadjusted or adjusted results, such as summary statis-
tics, confidence intervals (CI) or standard error (SE)
within group, treatment effect, CI/SE of treatment effect,
and the corresponding P-value were reported in the main
text and abstract. If results reported in the abstract were
not clear, we referred to the main text for type of analysis
used.
We also evaluated whether the reporting of adjusted
analyses adhered to the 2001 CONSORT guidelines. For
the 2006 cohort, we assessed whether articles were pub-
lished in a CONSORT endorsing journal based on the
journals' 'Instruction to Authors' (assessed June 2008).
Data regarding trial characteristics were extracted by two
reviewers (LY and SH), while outcome and adjusted anal-
ysis information were extracted by a single reviewer (LY).
Data Synthesis and Analysis
Frequency of adjusted analysis was expressed as the pro-
portion of trials that reported using adjusted analysis.
Comparisons of trial characteristics and adherence to the
2001 CONSORT Statement between 2000 and 2006 were
carried out by Chi-square test for categorical data or
Fisher's exact test if expected counts were less than five,
and Mann-Whitney test for continuous data. PercentageYu et al. Trials 2010, 11:59
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difference and corresponding precision based on 95%
confidence intervals (CI) were calculated to quantify the
change in reporting between 2000 and 2006. Similar anal-
yses were used for comparisons of trial characteristics
between trials that did or did not report adjusted analysis
within each cohort. Data were analyzed using Stata 9
(Stata Corporation, College Station, TX, USA) and a P-
value of less than 0.05 was considered to indicate statisti-
cal significance.
Results
Characteristics of trials
In total, 1735 citations were identified from December
2006 and 616 articles were included. Full details of
included and excluded articles are shown in Figure 1. Of
the 519 articles retrieved from 326 journals in 2000 and
616 from 316 journals in 2006, 355 and 421 parallel group
studies were included in this review, respectively (Figure
2). A significantly lower proportion of articles specified
the primary outcome in 2000 than 2006 (51% vs 65%,
respectively; P < 0.0001). In both years, most studies were
characterized by two study arms (74% for 2000 vs 78% for
2006), a single study centre (both 66%), and publication in
specialty journals (both 91%) (Table 1). The average sam-
ple size and number of trial outcomes were similar in
both years and most reported outcomes were continuous
(about 70%). Fewer studies performed stratified randomi-
sation in 2000 than in 2006 (16% vs 20%, respectively; P =
0.1).
Eighty four articles (24%) and 113 articles (27%) in 2000
and 2006, respectively, reported adjusted analyses per-
formed on at least one outcome in the Methods, Results,
or both sections.
Characteristics of trials that did or did not report adjusted 
analysis
There was a marked difference in the characteristics of
studies that did or did not report adjusted analysis in both
c o h o r t s .  A  h i g h e r  p r o p o r t i o n  o f  a r t i c l e s  r e p o r t i n g
adjusted analysis had specified primary outcomes,
involved multiple centers, had performed stratified ran-
domisation, and were published in general journals. Tri-
als with adjusted analysis recruited more participants and
had fewer outcomes (Figure 3).
Consistency of analysis reported between Methods and 
Results in articles reported adjusted analysis
Among the adjusted analyses articles, 79 and 109 articles
had a statistical methods section in 2000 and 2006,
respectively. For the outcome selected from each trial, we
examined the consistency of the type of analysis reported
in the Methods and Results sections. In 2000, 43 out of 79
articles (54%) explicitly specified adjusted analyses were
used in the Methods and had subsequently reported
them in the Results. Discrepancies between the informa-
tion in Methods and Results sections were found in 36
articles (46%). For example, two articles had specified
adjusted analysis in the Methods but reported only unad-
justed results in the Results and 24 (30%) articles did not
specify clearly the type of analysis used in the Results sec-
tion.
In 2006, the consistency of the type of analysis reported
in the Method and Results sections increased to 69% (74/
109) (P = 0.06; Difference [95% CI] = 13.5% [-0.6% to
27.5%]), while there was a reduction in the proportion of
articles that did not specify clearly the type of analysis
used in the Results section for the selected outcome (19/
109 = 17%) (P = 0.04; Difference [95% CI] = -12.9 (-25.3 to
-0.6)). Three articles specified adjusted analysis in the
Methods but reported only unadjusted results in the
Results. We contacted the authors of the 34 articles with
an inconsistency between the Methods and Results sec-
tion but only three responded.
Figure 1 Flow Chart of December 2006 Articles Eligible for Re-
view.
1735 PubMed citations 
856 excluded:
438 observational studies
154 reviews
80 editorial/letters
61 non-randomised trials studies
31 secondary publications
25 diagnostic test studies
21 methodology studies
14 economic evaluation studies
10 non-trial experiments
9 study protocols
6 qualitative studies
3 non-human studies
2 guidelines
2 case reports
879 full articles reviewed
263 excluded:
100 secondary publications
46 non-randomised trials studies
44 observational studies
33 non-trial experiments
10 editorial/letters
7 reviews
6 interim analysis reports
4 diagnostic test studies
3 economic evaluation studies
3 study protocols/study plan
2 methodology studies
2 case reports
1 qualitative study
1 non-human study
1 non English language
616 randomised trialsYu et al. Trials 2010, 11:59
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Figure 2 Flowchart diagram of articles retrieved and included in the review.Yu et al. Trials 2010, 11:59
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Table 1: Characteristics of articles of parallel group randomized trials by year of publication
Year of Publication 2000
(n = 355)
2006
(n = 421)
% difference†
(95% CI)
P-value
Outcome specification
Primary 180 (50.7%) 273 (64.9%) 14.1 (7.2 to 21.0) <0.0001
Unspecified 175 (49.3%) 148 (35.1%)
Centre involved*
Multiple centres 119 (34.1%) 138 (33.7%) -0.4 (-7.2 to 6.3) 0.9
Single centre 230 (65.9%) 272 (66.3%)
Number of intervention 
groups
261 (73.5%) 328 (77.9%) 0.2
2 57 (16.1%) 64 (15.2%)
3 37 (10.4%) 29 (6.9%)
> 3
Performed stratified 
randomisation
56 (15.8%) 85 (20.2%) 4.4 (-1.0 to 9.8) 0.1
Sample size
< 50 116 (32.7%) 129 (30.6%)
51 - 150 141 (39.7%) 169 (39.9%)
151 - 300 49 (13.8%) 52 (12.4%)
301 - 450 20 (5.6%) 27 (6.6%)
> 450 29 (8.2%) 44 (10.5%)
Median (10th to 90th 
percentile)
91 (27 to 394) 80 (28 to 462) 0.7
Journal type
General medical 31 (8.7%) 36 (8.6%) -0.1 (3.8 to -4.2) 0.9
Specialty 324 (91.3%) 385 (91.4%)
Number of outcomes per trial
Median (range) 15 (1, 131) 14 (1, 372) 0.2
Type of outcomes (n = 7132) (n = 8299) <0.0001
Continuous 4984 (69.9%) 5705 (68.7%)
Binary 1961 (27.5%) 2357 (28.4%)
Time-to-event 47 (0.6%) 128 (1.5%)
Ordinal 140 (2.0%) 98 (1.2%)
Categorical 0 11 (0.1%)
Adjusted analysis 84 (23.7%) 113 (26.8%) 3.1 (-2.9 to 9.3) 0.3
* Unclear: 6 for year 2000 and 11 for year 2006
† Percentage difference = percentage in 2006 - percentage in 2000Yu et al. Trials 2010, 11:59
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Details of adjusted analysis
Details of adjusted analysis are summarized in Table 2. In
the 2000 cohort, over 90% of articles had carried out
adjusted analysis on the primary outcome. Overall, the
majority of articles (80%) did not report the reasons for
a d j u s t m e n t  o r  h o w  t h e  c o v a r i a t e s  w e r e  s e l e c t e d  f o r
adjustment. Of the 78 articles that specified the covari-
ates, nine (12%) included covariates that were collected
after randomisation and 16 (20%) did not specify in the
Method section the methods used for adjustment. Fewer
than half of the articles included all of the stratification
factors used at randomisation in the adjusted analysis.
Very few (8% in 2000 and 9% in 2006) specified explicitly
whether the adjusted analysis was the primary or second-
ary analysis.
Eighty three articles (99%) in 2000 reported the statisti-
cal methods used for adjustment. Since outcomes were
predominately continuous, most studies used regression
methods (ANCOVA, ANOVA or multiple regressions)
for adjustment (Table 3). Binary outcomes and time-to-
event data were analysed mainly by logistic regression
and Cox regression, respectively. Stratified analyses (e.g.
Cochrane-Mantel-Haenszel or Chi-squared analysis) for
adjustment were used more often for binary outcomes
than other types of outcomes.
In the 2006 cohort, there was no evidence of change in
the reporting of the reason for adjustment (30%) and
choice of covariates (27%). More trials in 2006 had
adjusted for covariates that were believed to be correlated
with the outcomes (13% vs 7%) but only two articles
explicitly stated that the covariates selected for adjust-
ment were pre-specified. In addition, more covariates
were adjusted for than in 2000, especially outcomes col-
lected at baseline, but fewer multi-centre studies had
adjusted for centre effect. Use of statistical methods was
similar in both cohorts (Table 3).
Reporting of adjusted analysis
Table 4 presents the type of results reported in the
Results section and abstract. Fifty four articles in 2000
reported any results of adjusted or unadjusted analysis in
the Results section. Of these, 80% reported explicitly the
t ype  o f  a n a l y s i s  u s e d  t o  d e r i v e  t h e  P -v a l u e s  w h i l e  j u s t
under a half reported estimated treatment effects (e.g.
odds ratio or difference between means) and the corre-
sponding confidence intervals. Lack of reporting of
Figure 3 Comparison of characteristics of articles that did or did not report adjusted analysis for trials published in 2000 and 2006.
Difference in percentage
-30 -20 -10 0 10 20 30 40 50
Difference in 
percentage
(95% CI)
Specified primary outcome
PubMed2000 13.8 (5.1 to 22.5) 55/180 29/175
PubMed2006 26.8 (19.4 to 34.2) 99/273 14/148
Multi-centre
PubMed2000 26.0 (16.0 to 35.9) 49/119 35/230
PubMed2006 25.1 (15.6 to 34.6) 61/138 52/272
Stratified randomisation
PubMed2000 26.0 (12.1 to 39.8) 26/56 62/303
PubMed2006 35.6 (24.2 to 47.0) 47/85 66/336
Journal type (general medical vs specialty)
PubMed2000 27.1 (8.9 to 45.2) 15/31 69/324
PubMed2006 25.3 (8.4 to 42.2) 18/36 95/385
Sample size >= 200
PubMed2000 22.8 (10.9 to 34.8) 32/77 52/278
PubMed2006 36.0 (25.6 to 46.4) 57/106 56/315
Number of outcomes < 15
PubMed2000 -12.9 (-21.5 to -4.2) 27/162 57/193
PubMed2006 -12.8 (-21.3 to -4.4) 45/218 68/203
Higher percentage in articles 
reported adjusted analysis
Higher percentage in  articles 
did not report adjusted analysis
No./total articles 
reported adjusted 
analysis
No./total articles 
did not report 
adjusted analysisYu et al. Trials 2010, 11:59
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Table 2: Details of adjusted analysis
Year of publication 2000
(n = 84)*
2006
(n = 113)*
% difference
(95% CI)
P-value
Performed adjusted 
analysis on primary 
outcome†
50 (90.9%) 93 (93.9%) 30.0 (-5.9 to 12.0) 0.5
Reason for adjustment 0.4
Imbalance in 
covariates
9 (10.7%) 12 (10.6%)
Prognostic 
covariates
6 (7.1%) 15 (13.3%)
Both 0 3 (2.6%)
Other reasons ‡ 3 (3.6%) 4 (3.5%)
Not mentioned 66 (78.6%) 79 (69.9%)
Choice of covariates 0.5
All pre-specified 5 (5.9%) 8 (7.1%)
All suggested by 
data
12 (14.3%) 20 (17.7%)
Combination of 
pre-specified and 
post hoc
03  ( 2 . 6 % )
Not mentioned 67 (79.8%) 82 (72.6%)
Number of covariates 
adjusted for §
0.02 ||
1 39 (46.4%) 36 (31.8%)
2 23 (27.4%) 33 (29.2%)
3-5 14 (16.7%) 25 (22.1%)
6-9 2 (2.4%) 12 (10.6%)
Not mentioned 6 (7.1%) 7 (6.2%)
Covariate used for 
adjustment
Outcome 
assessed at 
baseline
33/62 (53.2%) 55/81 (67.9%) 14.7 (-1.4 to 30.7) 0.07
Centre/Country 31/49 (63.3%) 25/61 (41.0%) -22.3 (-40.6 to -39.9) 0.02
Assessed after 
randomisation
9/78 (11.8%) 9/107 (8.4%) -3.1 (-12.0 to 5.7) 0.5
All stratification factors 
were adjusted for
11/25 (44.0%) 20/46 (43.5%) -0.5 (-24.7 to 23.6) 1.0
Explicitly specified 
nature of analysis
Primary analysis 2 5
Secondary/
sensitivity analysis
55Yu et al. Trials 2010, 11:59
http://www.trialsjournal.com/content/11/1/59
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results, for the selected outcome, in the abstract was
more severe. Over 80% of the articles did not report
either the treatment effect or the corresponding confi-
dence interval in the abstract. Even P-values were
reported in only 31% of the studies.
Overall, there was an increase in reporting any adjusted
results in the abstract in 2006 when compared with the
2000 cohort (Table 4). However, in both years a high per-
centage of articles which used adjustment did not report
any adjusted treatment effect. Only 26/50 (52%) in 2000
and 61/93 (66%) in 2006 reported the results of any treat-
ment comparison (i.e. treatment effect estimate, confi-
dence interval, or P-value) in the abstract. Of these, 50%
and 61% reported any adjusted results, respectively, but
in both years only 30% presented the adjusted treatment
effect. Confidence intervals were rarely provided.
Adherence to the CONSORT guidelines
With regard to how adjusted analysis should be reported
according to the revised CONSORT Statement, there was
a slight improvement in some items five years after the
revision but the overall adherence is still low (Table 5).
Although fewer articles in 2000 reported that stratified
randomisation was performed, the proportion that
adjusted for any stratification variables was in fact higher
than in the 2006 cohort (46% in 2000 vs. 35% in 2006).
Reporting of both adjusted and unadjusted results was
poor. Only four out of 84 articles and 11 out of 113 arti-
cles in 2000 and 2006, respectively, reported both results.
Of 21 articles (25%) in 2000 that mentioned both adjusted
and unadjusted analyses, seven reported only the unad-
justed results because the results were similar for both
analyses. Similarly, 27 articles had performed both analy-
ses in 2006, of which two reported the adjusted results
and five reported the unadjusted results because both
results were similar. In addition, four studies in that
cohort had reported that the significance of treatment
effect was different from unadjusted analysis after adjust-
ing for covariates.
In 2006, 65 of the 113 (57%) articles that reported
adjusted analysis were published in CONSORT-endors-
ing journals. Among these, 23 (35%) specified the ratio-
nale for the adjusted analysis performed compared with
11 of the 48 (23%) articles from journals that did not
endorse CONSORT. The number of articles which
reported both adjusted and unadjusted results was
slightly higher in CONSORT endorsing journals com-
pared to non endorsing journals (seven vs four articles,
respectively).
Discussion
Our study provides a comprehensive assessment and
comparison of the quality of reporting of adjusted analy-
sis before and after the revision of the CONSORT State-
ment in 2001. In our review, we found that the
characteristics of published reports of parallel group ran-
domised trials indexed in PubMed in 2000 and 2006 were
similar, though there was a significant improvement in
primary outcome specification in 2006. Only a quarter of
randomised trials reported any covariate adjustment
analysis. The prevalence of adjusted analysis in our broad
cohorts is much lower than the 72% reported in a previ-
ous review which was restricted to four high impact gen-
eral medical journals in 1997 [1] and 64% in a recent
Type of outcomes 0.8
Binary 13 (15.5%) 19 (16.8%)
Continuous 65 (77.4%) 81 (71.7%)
Ordinal 1 (1.2%) 3 (2.6%)
Time-to-event 5 (5.9%) 10 (8.9%)
Adjusted analysis 
method used was 
mentioned for specific 
outcome in the 
Method section
62/78 ¶(79.5%) 88/109 ¶ (80.7%) 1.2 (-10.4 to 12.9) 0.8
*One adjusted analysis selected per study only
†Number of studies that have specified primary outcomes: Year 2000 = 55 and Year 266 = 99
‡Year 2000: Clinical relevance (n = 1), significant at 3 weeks after randomisation (n = 1), exploring role of baseline variables (n = 1); Year 2006: 
Mediated treatment effect on outcome (n = 1), related to compliance/adherence of treatment (n = 2), effect of outcome decline over time (n 
= 1)
§Year 2000: 6 studies did not report number of covariates; Year 2006: 6 studies did not report number of covariates and 1 stated at least 2 
covariates
|| Mann-Whitney test
¶Did not have statistical method section: Year 2000 (n = 6), Year 2006 (n = 5)
Table 2: Details of adjusted analysis (Continued)Yu et al. Trials 2010, 11:59
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review conducted by Austin et al [14]. Another review
looked at 34 scientific medical journals in 1998 with a
high impact factor and reported 31% of articles had spec-
ified adjustment for confounding factors [15]. A further
study found similar percentage of adjusted analysis in
clinical trials of traumatic brain injury [16]. To our
knowledge, these three studies are the only previous such
studies addressing this issue. By including journals from
all specialties, we believe that the frequency of adjusted
analysis in our cohorts is representative of the overall
randomised trial literature.
We found that analyses specified in the Methods sec-
tions did not necessarily reflect how the results reported
in the Results section were obtained. Often the method
was either not clearly specified or the results were
obtained from different analyses from the specified ones.
Readers often trust that the results were derived from
analyses specified in the Method section. Our findings
have shown that further clarification for reporting results
is needed; especially in studies involving adjusted analy-
sis.
Although many authors have discussed how adjusting
for baseline covariates in the analysis of RCTs can
improve the power of analyses of treatment effect and
account for any imbalances in baseline covariates [4,5,17-
19], the debate on whether this practice should be carried
out remains unresolved. Many recommend that the anal-
ysis should be undertaken only if the methods of analysis
and choice of covariates are pre-specified in the protocol
or statistical analysis plan [1,6-8]. Unfortunately, the
rationale for adjustment and choice of covariates were
m i s s i n g  i n  m o s t  o f  t h e  a r t i c l e s  w e  r e v i e w e d ,  a l t h o u g h
there has been an improvement in the overall reporting of
adjusted analysis in trial reports published in 2006 com-
pared to 2000. This lack of pre-specification echoes the
findings in the recent review carried out by Chan et al
[20]. They found that most trials that mentioned adjusted
analysis in either the protocol or article had discrepancies
between the two (18/28). Among 18 trials with published
Table 3: Methods used in adjusted analysis
Year of Publication 2000
(n = 84)
2006
(n = 113)
Continuous data 65 (77.4%) 81 (71.7%)
ANOVA/ANCOVA 50 (76.9%) 56 (69.1%)
Multiple regression method* 7 (10.8%) 19 (23.5%)
Stratified analysis 1 (1.5%) 0
Other† 6 (9.2%) 6 (7.4%)
Not mentioned 1 (1.5%) 0
Binary data 13 (15.5%) 19 (16.8%)
Logistic regression 6 (46.1%) 11 (57.9%)
Stratified analysis (Cochrane-Mantel-
Haenszel test)
5 (38.5%) 5 (26.3%)
Other‡ 2 (15.4%) 3 (15.8%)
Ordinal data 1 (1.2%) 3 (2.6%)
Stratified analysis (Cochrane-Mantel-
Haenszel test)
1 (100%) 1 (33.3%)
Nonlinear mixed effect model 0 1 (33.3%)
Ordinal logistic regression 0 1 (33.3%)
Time to event data 5 (5.9%) 10 (8.9%)
Cox proportional hazard 5 (100%) 9 (90.0%)
Stratified log rank test 0 1 (10.0%)
* Including random effect and mixed effect models
† Including GEE, GLM, ANCOVA for rank data, Zellner seemingly unrelated regression, Poisson model, Van Elteren test
‡ Including non-parametric Generalized mixed effect model, GEE, non-parametric ANCOVAYu et al. Trials 2010, 11:59
http://www.trialsjournal.com/content/11/1/59
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Table 4: Presentation of results in the Results section and abstract for studies reporting adjusted analysis
Year of Publication Results Section Abstract
2000
(n = 54)
2006
(n = 89)
P-value 2000
(n = 71)*
2006
(n = 101)†
P-value
Summary statistics for each 
group
0.7 0.5
Unadjusted only 42 (78%) 70 (80%) 26 (37%) 45 (44%)
Adjusted only 6 (11%) 12 (14%) 3 (4%) 5 (5%)
Both 4 (7%) 3 (3%) 0 0
None/not clear 2 (4%) 3 (3%) 42 (59%) 51 (51%)
Confidence interval/SE 
within group
0.2 1.0
Unadjusted only 12 (22%) 11 (13%) 2 (3%) 2 (2%)
Adjusted only 6 (11%) 10 (11%) 2 (3%) 4 (4%)
Both 1 (2%) 0 0 (%) 0
None/not clear 35 (65%) 67 (76%) 67 (94%) 95 (94%)
Treatment effect 0.4 0.1
Unadjusted only 5 (9%) 5 (6%) 3 (4%) 5 (5%)
Adjusted only 17 (31%) 35 (39%) 5 (7%) 19 (19%)
Both 4 (7%) 12 (13%) 1 (2%) 1 (1%)
None/not clear 28 (52%) 37 (42%) 62 (87%) 76 (75%)
Confidence interval/SE of 
treatment effect
0.6 0.4
Unadjusted only 6 (11%) 5 (6%) 2 (3%) 6 (6%)
Adjusted only 16 (30%) 24 (27%) 3 (4%) 17 (17%)
Both 4 (7%) 10 (11%) 1 (2%) 1 (1%)
None/not clear 28 (52%) 49 (56%) 65 (91%) 77 (76%)
P-value for treatment effect 0.2 0.2
Unadjusted only 9 (17%) 8 (9%) 9 (13%) 13 (13%)
Adjusted only 27 (50%) 52 (59%) 13 (18%) 30 (30%)
Both 7 (13%) 17 (19%) 0 2 (2%)
None/not clear 11 (20%) 11 (13%) 49 (69%) 56 (55%)
*13 studies did not report the selected outcome in abstract
† 2 studies did not have abstract and 10 studies did not report the selected outcome in the abstract
adjusted analyses, 12 included covariates that were not
pre-specified in the protocol ten of which did not men-
tion any adjusted analysis in the protocol.
Most articles that gave their reason for adjustment or
choice of covariates were not in accordance with the
guidelines' recommendations [6,7]. Few studies per-
formed and reported the adjusted analysis adequately.
For example, where procedures such as stratified ran-
domisation or minimisation methods were used, the
analysis without adjustment of stratifying variables could
over-estimate the standard error of the treatment effect
as well as distort the P-value [21]. Our findings indicate
that trials that performed these procedures often did not
adjust for stratification/minimisation factors. Further-
more, covariates assessed after randomisation require
special attention because their relationship with the studyYu et al. Trials 2010, 11:59
http://www.trialsjournal.com/content/11/1/59
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outcome could be confounded by treatment; a different
analytical approach is needed [6,7,22,23]. However, we
found that some trials included such covariates in the
analyses, as has been documented by others [24,25].
Generally, the reporting of adjusted analysis was com-
parable between the two cohorts we reviewed, which rep-
resent trials published before and after the revision of the
CONSORT Statement in 2001. Reporting of the main
results, such as treatment group summary statistics,
treatment effect and confidence intervals, as suggested by
CONSORT, were often lacking or unclear in both the
Results section and abstract. Such deficiencies could be
due to the fact that much more attention has been given
to other issues, such as adequacy and transparency of
sample size calculation, blinding and randomisation
methods, etc, that have already been addressed more
often in other systematic reviews [26,27]. Treatment
effect estimates from unadjusted and adjusted analyses
are not directly comparable because the former gives
population-averaged estimates of treatment effect while
the latter assesses subject-specific estimates, so it is
important that these results are reported clearly so that
the treatment effect can be interpreted correctly. This
argument is most pertinent in analyses of RCTs with non-
continuous outcomes because the treatment effect esti-
mate changes when covariates are included in the analysis
[3].
There is little previous evidence about the use and
reporting of adjusted analysis in RCTs (19). However, two
recent studies reported the impact of selective reporting
of adjusted estimates in meta-analyses of observational
studies [28,29]. Both studies found that the pooled unad-
justed effects differed according to whether studies con-
tributed both adjusted and unadjusted estimates to the
meta-analyses or only unadjusted effects. To what extent
this lack of clarity in reporting adjusted analyses in RCTs
could represent reporting bias that may affect subsequent
meta-analyses is unclear. We appreciate that unclear
reporting of results does not necessarily reflect poor
research conduct, but there is clear evidence suggesting
that quality of reporting is associated with bias in the esti-
mation of treatment effect [12,30].
We identified slightly better reporting of key method-
ological items in CONSORT endorsing as opposed to
non CONSORT endorsing journals. However, because
there was a time-lag between article publication (Decem-
ber 2006) and when the journal 'Instructions to Authors'
were assessed (June 2008) these results should be viewed
with some caution. A limitation of this study is that, apart
from the trial characteristics for the 2006 cohort, data
were extracted by a single reviewer. However, the
reviewer revisited the data extraction a few months after
the first extraction as a quality assurance procedure. We
also used slightly different sampling techniques between
Table 5: Ad herence to the CONSORT recommendations
Year of publication 2000
(n = 84)
2006
(n = 113)
Relative risk
(95% CI)
P-value
Have adjusted for any 
stratification variables*
26 (46%) 30 (35%) 0.76(0.51, 1.14) 0.2
Have specified 
rationale for any 
adjusted analysis
18 (21%) 34 (30%) 1.40(0.85, 2.31) 0.2
Have specified 
statistical method 
used for adjusted 
analysis
83 (99%) 113 (100%) 1.0 (0.97, 1.03) 1.0
Have reported results 
from adjusted analysis 
only2
18 (21%) 29 (26%) 1.20 (0.71, 2.01) 0.5
Have reported results 
from both adjusted 
and unadjusted 
analysis†
4 (5%) 11 (10%) 2.04 (0.67, 6.20) 0.3
* n = 56 for Year 2000 and n = 85 for Year 2006
†Results included summary in each group, effect size, and confidence intervalYu et al. Trials 2010, 11:59
http://www.trialsjournal.com/content/11/1/59
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the two years. The 2000 cohort included all reports of
randomised trials published in December 2000 and
indexed in PubMed by July 2002 to account for the lag in
PubMed indexing. For pragmatic reasons, the 2006
cohort included those trials indexed in PubMed in
December (as of March 2007). This meant that we were
able to capture our sample of trials within one search but
may have missed a small number of trials which were
published in December 2006 but indexed in PubMed
after March 2007.
In conclusion, there was no evidence of change in the
reporting of adjusted analysis results five years after the
revision of CONSORT Statement. Furthermore, overall
quality of reporting of adjusted analysis and adherence to
CONSORT recommendations remain low. The rationale
for covariate adjustment, methods of analysis and choice
of covariates for adjustment should be fully reported so
that readers can assess whether the adjusted analysis has
been adequately carried out and, therefore, should be
made transparent in the trial reports. Finally, both unad-
justed and adjusted results, which analysis represents the
primary analysis, and whether the adjusted analysis was
pre-specified in the protocol should also be included in
the report.
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